Free Trial

DIH Holding US (DHAI) Competitors

DIH Holding US logo
$1.11 -0.12 (-9.76%)
Closing price 04:00 PM Eastern
Extended Trading
$1.10 -0.02 (-1.35%)
As of 07:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

DHAI vs. NYXH, RCEL, CATX, PROF, AVR, OBIO, LAKE, SKIN, KRMD, and BWAY

Should you be buying DIH Holding US stock or one of its competitors? The main competitors of DIH Holding US include Nyxoah (NYXH), AVITA Medical (RCEL), Perspective Therapeutics (CATX), Profound Medical (PROF), Anteris Technologies Global (AVR), Orchestra BioMed (OBIO), Lakeland Industries (LAKE), Beauty Health (SKIN), KORU Medical Systems (KRMD), and BrainsWay (BWAY). These companies are all part of the "medical equipment" industry.

DIH Holding US vs.

Nyxoah (NASDAQ:NYXH) and DIH Holding US (NASDAQ:DHAI) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, risk, community ranking, dividends, valuation, earnings, media sentiment, institutional ownership and profitability.

DIH Holding US has a net margin of 0.00% compared to Nyxoah's net margin of -1,043.93%. DIH Holding US's return on equity of -5.07% beat Nyxoah's return on equity.

Company Net Margins Return on Equity Return on Assets
Nyxoah-1,043.93% -51.68% -40.11%
DIH Holding US N/A -5.07%3.35%

In the previous week, Nyxoah had 2 more articles in the media than DIH Holding US. MarketBeat recorded 2 mentions for Nyxoah and 0 mentions for DIH Holding US. DIH Holding US's average media sentiment score of 1.00 beat Nyxoah's score of 0.00 indicating that DIH Holding US is being referred to more favorably in the news media.

Company Overall Sentiment
Nyxoah Neutral
DIH Holding US Positive

27.8% of DIH Holding US shares are held by institutional investors. 49.6% of DIH Holding US shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Nyxoah currently has a consensus price target of $17.00, indicating a potential upside of 56.18%. Given Nyxoah's stronger consensus rating and higher probable upside, analysts plainly believe Nyxoah is more favorable than DIH Holding US.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nyxoah
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
DIH Holding US
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Nyxoah received 38 more outperform votes than DIH Holding US when rated by MarketBeat users.

CompanyUnderperformOutperform
NyxoahOutperform Votes
38
71.70%
Underperform Votes
15
28.30%
DIH Holding USN/AN/A

Nyxoah has a beta of 1.35, indicating that its share price is 35% more volatile than the S&P 500. Comparatively, DIH Holding US has a beta of -0.57, indicating that its share price is 157% less volatile than the S&P 500.

DIH Holding US has higher revenue and earnings than Nyxoah.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nyxoah$4.70MN/A-$46.77M-$1.87-5.82
DIH Holding US$64.47M0.75-$8.44MN/AN/A

Summary

DIH Holding US beats Nyxoah on 8 of the 14 factors compared between the two stocks.

Get DIH Holding US News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHAI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHAI vs. The Competition

MetricDIH Holding USSurgical & medical instruments IndustryBusiness SectorNASDAQ Exchange
Market Cap$48.04M$4.83B$7.51B$9.14B
Dividend YieldN/A52.58%2.23%4.00%
P/E RatioN/A26.1328.7817.53
Price / Sales0.7561.29102.3380.11
Price / CashN/A50.8929.2032.90
Price / Book-1.487.896.154.67
Net Income-$8.44M$13.87M$137.20M$224.69M
7 Day Performance-6.69%4.06%3.30%3.32%
1 Month Performance2.16%11.17%5.70%5.36%
1 Year PerformanceN/A33.28%24.75%22.59%

DIH Holding US Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHAI
DIH Holding US
N/A$1.11
-9.8%
N/AN/A$45.00M$64.47M0.00N/A
NYXH
Nyxoah
2.7951 of 5 stars
$9.33
+0.9%
$17.00
+82.2%
+142.2%$232.69M$5.08M-4.99110News Coverage
Positive News
RCEL
AVITA Medical
2.0734 of 5 stars
$8.82
-3.5%
$18.00
+104.1%
-37.8%$231.24M$60.04M-3.96130
CATX
Perspective Therapeutics
3.1012 of 5 stars
$3.40
-2.9%
$15.14
+345.4%
N/A$229.80M$1.43M0.0070
PROF
Profound Medical
2.5848 of 5 stars
$7.45
-1.6%
$14.25
+91.3%
-8.4%$227.31M$8.98M-5.56150
AVR
Anteris Technologies Global
N/A$5.60
-6.7%
$16.50
+194.6%
N/A$201.26M$2.71M0.00138Quiet Period Expiration
OBIO
Orchestra BioMed
2.0221 of 5 stars
$5.13
-6.2%
$15.80
+208.0%
-39.4%$195.01M$2.65M-3.194
LAKE
Lakeland Industries
4.3315 of 5 stars
$25.82
-1.5%
$27.50
+6.5%
+48.7%$191.22M$151.82M-286.891,750Positive News
SKIN
Beauty Health
1.9654 of 5 stars
$1.52
-2.3%
$2.55
+68.3%
-28.4%$188.05M$347.62M-3.611,030Positive News
KRMD
KORU Medical Systems
1.7138 of 5 stars
$3.95
-0.3%
$4.13
+4.4%
+97.6%$181.06M$31.99M-15.8080High Trading Volume
BWAY
BrainsWay
2.9271 of 5 stars
$9.43
+0.3%
$13.17
+39.6%
+60.6%$177.41M$38.63M94.31120Gap Up

Related Companies and Tools


This page (NASDAQ:DHAI) was last updated on 1/21/2025 by MarketBeat.com Staff
From Our Partners